1,25-Dihydroxyvitamin D3 suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation

Yunzi Chen, Juan Kong, Tao Sun, George Li, Frances L. Szeto, Weicheng Liu, Dilip K. Deb, Youli Wang, Qun Zhao, Ravi Thadhani, Yan Chun Li

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Plasminogen activator inhibitor (PAI)-1 is a major fibrinolytic inhibitor. High PAI-1 is associated with increased renal and cardiovascular disease risk. Previous studies demonstrated PAI-1 down-regulation by 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), but the molecular mechanism remains unknown. Here we show that exposure of mouse embryonic fibroblasts to TNFα or LPS led to a marked induction of PAI-1, which was blunted by 1,25(OH)2D3, NF-κB inhibitor or p65 siRNA, suggesting the involvement of NF-κB in 1,25(OH)2D 3-induced repression. In mouse Pai-1 promoter a putative cis-κB element was identified at -299. EMSA and ChIP assays showed that TNF-α increased p50/p65 binding to this κB site, which was disrupted by 1,25(OH)2D3. Luciferase reporter assays showed that PAI-1 promoter activity was induced by TNFα or LPS, and the induction was blocked by 1,25(OH)2D3. Mutation of the κB site blunted TNFα, LPS or 1,25(OH)2D3 effects. 1,25(OH)2D3 blocked IκBα degradation and arrested p50/p65 nuclear translocation. In mice LPS stimulated PAI-1 expression in the heart and macrophages, and the stimulation was blunted by pre-treatment with a vitamin D analog. Together these data demonstrate that 1,25(OH) 2D3 down-regulates PAI-1 by blocking NF-κB activation. Inhibition of PAI-1 production may contribute to the reno- and cardio-protective effects of vitamin D.

Original languageEnglish (US)
Pages (from-to)241-247
Number of pages7
JournalArchives of Biochemistry and Biophysics
Volume507
Issue number2
DOIs
StatePublished - Mar 15 2011
Externally publishedYes

Fingerprint

Calcitriol
Plasminogen Activator Inhibitor 1
Chemical activation
Inflammation
Vitamin D
Assays
Down-Regulation
blocking factor
Macrophages
Fibroblasts
Luciferases
Small Interfering RNA
Cardiovascular Diseases
Kidney
Degradation
Mutation

Keywords

  • Gene regulation
  • NF-κB
  • PAI-1
  • Vitamin D

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology

Cite this

1,25-Dihydroxyvitamin D3 suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation. / Chen, Yunzi; Kong, Juan; Sun, Tao; Li, George; Szeto, Frances L.; Liu, Weicheng; Deb, Dilip K.; Wang, Youli; Zhao, Qun; Thadhani, Ravi; Li, Yan Chun.

In: Archives of Biochemistry and Biophysics, Vol. 507, No. 2, 15.03.2011, p. 241-247.

Research output: Contribution to journalArticle

Chen, Yunzi ; Kong, Juan ; Sun, Tao ; Li, George ; Szeto, Frances L. ; Liu, Weicheng ; Deb, Dilip K. ; Wang, Youli ; Zhao, Qun ; Thadhani, Ravi ; Li, Yan Chun. / 1,25-Dihydroxyvitamin D3 suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation. In: Archives of Biochemistry and Biophysics. 2011 ; Vol. 507, No. 2. pp. 241-247.
@article{f15b5471fe7542d28e9e49c367ba3753,
title = "1,25-Dihydroxyvitamin D3 suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation",
abstract = "Plasminogen activator inhibitor (PAI)-1 is a major fibrinolytic inhibitor. High PAI-1 is associated with increased renal and cardiovascular disease risk. Previous studies demonstrated PAI-1 down-regulation by 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), but the molecular mechanism remains unknown. Here we show that exposure of mouse embryonic fibroblasts to TNFα or LPS led to a marked induction of PAI-1, which was blunted by 1,25(OH)2D3, NF-κB inhibitor or p65 siRNA, suggesting the involvement of NF-κB in 1,25(OH)2D 3-induced repression. In mouse Pai-1 promoter a putative cis-κB element was identified at -299. EMSA and ChIP assays showed that TNF-α increased p50/p65 binding to this κB site, which was disrupted by 1,25(OH)2D3. Luciferase reporter assays showed that PAI-1 promoter activity was induced by TNFα or LPS, and the induction was blocked by 1,25(OH)2D3. Mutation of the κB site blunted TNFα, LPS or 1,25(OH)2D3 effects. 1,25(OH)2D3 blocked IκBα degradation and arrested p50/p65 nuclear translocation. In mice LPS stimulated PAI-1 expression in the heart and macrophages, and the stimulation was blunted by pre-treatment with a vitamin D analog. Together these data demonstrate that 1,25(OH) 2D3 down-regulates PAI-1 by blocking NF-κB activation. Inhibition of PAI-1 production may contribute to the reno- and cardio-protective effects of vitamin D.",
keywords = "Gene regulation, NF-κB, PAI-1, Vitamin D",
author = "Yunzi Chen and Juan Kong and Tao Sun and George Li and Szeto, {Frances L.} and Weicheng Liu and Deb, {Dilip K.} and Youli Wang and Qun Zhao and Ravi Thadhani and Li, {Yan Chun}",
year = "2011",
month = "3",
day = "15",
doi = "10.1016/j.abb.2010.12.020",
language = "English (US)",
volume = "507",
pages = "241--247",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - 1,25-Dihydroxyvitamin D3 suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation

AU - Chen, Yunzi

AU - Kong, Juan

AU - Sun, Tao

AU - Li, George

AU - Szeto, Frances L.

AU - Liu, Weicheng

AU - Deb, Dilip K.

AU - Wang, Youli

AU - Zhao, Qun

AU - Thadhani, Ravi

AU - Li, Yan Chun

PY - 2011/3/15

Y1 - 2011/3/15

N2 - Plasminogen activator inhibitor (PAI)-1 is a major fibrinolytic inhibitor. High PAI-1 is associated with increased renal and cardiovascular disease risk. Previous studies demonstrated PAI-1 down-regulation by 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), but the molecular mechanism remains unknown. Here we show that exposure of mouse embryonic fibroblasts to TNFα or LPS led to a marked induction of PAI-1, which was blunted by 1,25(OH)2D3, NF-κB inhibitor or p65 siRNA, suggesting the involvement of NF-κB in 1,25(OH)2D 3-induced repression. In mouse Pai-1 promoter a putative cis-κB element was identified at -299. EMSA and ChIP assays showed that TNF-α increased p50/p65 binding to this κB site, which was disrupted by 1,25(OH)2D3. Luciferase reporter assays showed that PAI-1 promoter activity was induced by TNFα or LPS, and the induction was blocked by 1,25(OH)2D3. Mutation of the κB site blunted TNFα, LPS or 1,25(OH)2D3 effects. 1,25(OH)2D3 blocked IκBα degradation and arrested p50/p65 nuclear translocation. In mice LPS stimulated PAI-1 expression in the heart and macrophages, and the stimulation was blunted by pre-treatment with a vitamin D analog. Together these data demonstrate that 1,25(OH) 2D3 down-regulates PAI-1 by blocking NF-κB activation. Inhibition of PAI-1 production may contribute to the reno- and cardio-protective effects of vitamin D.

AB - Plasminogen activator inhibitor (PAI)-1 is a major fibrinolytic inhibitor. High PAI-1 is associated with increased renal and cardiovascular disease risk. Previous studies demonstrated PAI-1 down-regulation by 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), but the molecular mechanism remains unknown. Here we show that exposure of mouse embryonic fibroblasts to TNFα or LPS led to a marked induction of PAI-1, which was blunted by 1,25(OH)2D3, NF-κB inhibitor or p65 siRNA, suggesting the involvement of NF-κB in 1,25(OH)2D 3-induced repression. In mouse Pai-1 promoter a putative cis-κB element was identified at -299. EMSA and ChIP assays showed that TNF-α increased p50/p65 binding to this κB site, which was disrupted by 1,25(OH)2D3. Luciferase reporter assays showed that PAI-1 promoter activity was induced by TNFα or LPS, and the induction was blocked by 1,25(OH)2D3. Mutation of the κB site blunted TNFα, LPS or 1,25(OH)2D3 effects. 1,25(OH)2D3 blocked IκBα degradation and arrested p50/p65 nuclear translocation. In mice LPS stimulated PAI-1 expression in the heart and macrophages, and the stimulation was blunted by pre-treatment with a vitamin D analog. Together these data demonstrate that 1,25(OH) 2D3 down-regulates PAI-1 by blocking NF-κB activation. Inhibition of PAI-1 production may contribute to the reno- and cardio-protective effects of vitamin D.

KW - Gene regulation

KW - NF-κB

KW - PAI-1

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=79951946021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951946021&partnerID=8YFLogxK

U2 - 10.1016/j.abb.2010.12.020

DO - 10.1016/j.abb.2010.12.020

M3 - Article

VL - 507

SP - 241

EP - 247

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

IS - 2

ER -